Clinical Trial Update: MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MSI-78 topical cream to oral ofloxacin for infected diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• MSI-78 topical cream (MSI-78 topical cream)
• OFLOXACIN (OFLOXACIN)

Snippet

Sponsor: Abeona Therapeutics, Inc | Conditions: Diabetic Foot Ulcers | Phase 3 | Status: COMPLETED